Valuation: BioNTech SE

Market Cap 21.04B 24.13B 19.87B 18.04B 33.8B 2,315B 33.94B 238B 91.84B 1,177B 90.65B 88.63B 3,788B P/E 2026 *
-14.7x
P/E 2027 * -15.4x
Enterprise Value 9.67B 11.09B 9.13B 8.29B 15.54B 1,064B 15.61B 109B 42.22B 541B 41.67B 40.75B 1,741B EV / Sales 2026 *
5.35x
EV / Sales 2027 * 6.08x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day-2.64%
1 week-0.69%
Current month-5.46%
1 month-15.08%
3 months+5.69%
6 months+7.56%
Current year+0.90%
1 week 95.32
Extreme 95.315
103
1 month 95.32
Extreme 95.315
120.33
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
374.58
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Executive Officer 61 02/06/2008
Chief Tech/Sci/R&D Officer 59 01/01/2018
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Chairman 56 02/06/2008
Director/Board Member 69 02/06/2008
Director/Board Member 65 01/01/2018
Date Insider Type Main position Quantity % Market Cap. Importance
16/09/26 Sell

Chief Executive Officer

-15,000 0.0062%
14/09/26 Sell

Chief Executive Officer

-41,000 0.0170%
10/09/26 Sell

Chief Executive Officer

-20,500 0.0085%
Change 5-day change 1-year change 3-year change Capi.($)
-2.64%-0.69%-0.17%-13.01% 24.13B
-0.31%+5.79%+47.13%+99.00% 70.88B
+0.39%+2.06%+39.38%+78.27% 62.49B
+0.50%+7.13%+33.27%+16.01% 26.34B
-3.21%-7.27%-17.10%+356.10% 26.21B
+0.71%+8.03%+25.03%-12.74% 20.72B
-1.26%-7.81%+156.15%+320.43% 15.36B
-0.22%+3.99%+45.54%+172.46% 14.46B
+0.73%+1.71%-5.51%+849.47% 14.24B
+0.04%-0.77%-9.40%+477.72% 14.06B
Average -0.53%+1.41%+31.43%+234.37% 28.89B
Weighted average by Cap. -0.45%+1.33%+33.20%+163.79%

Financials

2026 *2027 *
Net sales 1.81B 2.07B 1.71B 1.55B 2.9B 199B 2.91B 20.43B 7.89B 101B 7.78B 7.61B 325B 1.81B 2.08B 1.71B 1.55B 2.91B 199B 2.92B 20.49B 7.91B 101B 7.8B 7.63B 326B
Net income -1.38B -1.58B -1.3B -1.18B -2.21B -151B -2.22B -15.57B -6.01B -77.02B -5.93B -5.8B -248B -1.31B -1.5B -1.24B -1.12B -2.11B -144B -2.11B -14.82B -5.72B -73.31B -5.65B -5.52B -236B
Net Debt -11.37B -13.04B -10.73B -9.75B -18.26B -1,251B -18.34B -129B -49.62B -636B -48.97B -47.89B -2,046B -10.03B -11.5B -9.47B -8.6B -16.11B -1,104B -16.18B -113B -43.77B -561B -43.2B -42.24B -1,805B
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
18/09/26 $96.06 -2.64% 1,195,345
17/09/26 $98.66 +2.95% 708,502
16/09/26 $95.83 -0.89% 407,603
15/09/26 $96.69 -2.20% 590,903
14/09/26 $98.86 +2.20% 1,222,144
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
83.76EUR
Average target price
102.91EUR
Spread / Average Target
+22.86%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!